Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin.

Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin.

Item
http://www.wikidata.org/entity/Q48284759
Mitogenic and antiadipogenic properties of human growth hormone in differentiating human adipocyte precursor cells in primary culture.Neuronal M3 muscarinic acetylcholine receptors are essential for somatotroph proliferation and normal somatic growth.BAP/SKB Young Psychopharmacologist Award Towards a neuroendocrinology of obsessive-compulsive disorder.Mutants of human insulin-like growth factor II (IGF II). Expression and characterization of truncated IGF II and of two naturally occurring variants.Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.Glucagon stimulates GH secretion after intramuscular but not intravenous administration. Evidence against the assumption that glucagon per se has a GH-releasing activity.The growth hormone response to pyridostigmine plus growth hormone releasing hormone is not influenced by pubertal maturation.Insulin-like growth factor-I restores the reduced somatostatinergic tone controlling growth hormone secretion in cirrhotic rats.Prolonged treatment with glycerophosphocholine, an acetylcholine precursor, does not disclose the potentiating effect of cholinesterase inhibitors on GHRH-induced somatotroph secretion in anorexia nervosa.Enhanced response of growth hormone to growth hormone-releasing hormone and a decreased content of hypothalamic somatostatin in a stress-induced rat model of depression.The evaluation of hypothalamic somatostatin tone using pyridostigmine and thyrotropin releasing hormone in patients with acromegaly.A neuroendocrinological approach to evidence an impairment of central cholinergic function in aging.Is the persistence of isolated GH deficiency in adulthood predicted by anatomical hypothalamic-pituitary alterations?Effect of galanin on the growth hormone (GH) response to GH-releasing hormone in patients with Cushing's disease.Testing with growth hormone-releasing factor (GRF(1-29)NH2) and somatomedin C measurements for the evaluation of growth hormone deficiency.The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy.
P2860

Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin.

Item
http://www.wikidata.org/entity/Q48284759
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Cholinergic agonist and antago ...... for mediation by somatostatin.
@en
Cholinergic agonist and antago ...... for mediation by somatostatin.
@nl
type
label
Cholinergic agonist and antago ...... for mediation by somatostatin.
@en
Cholinergic agonist and antago ...... for mediation by somatostatin.
@nl
prefLabel
Cholinergic agonist and antago ...... for mediation by somatostatin.
@en
Cholinergic agonist and antago ...... for mediation by somatostatin.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Cholinergic agonist and antago ...... for mediation by somatostatin.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698